These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8485913)

  • 21. Complement deposits in epidermal cells after ultraviolet B exposure.
    Rauterberg A; Jung EG; Rauterberg EW
    Photodermatol Photoimmunol Photomed; 1993 Aug; 9(4):135-43. PubMed ID: 8318429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
    Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
    J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of circulating and tissue-fixed immune complexes in cutaneous necrotizing vasculitis.
    Imamura S; Yanase K
    Acta Derm Venereol; 1980; 60(5):389-92. PubMed ID: 6162308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
    Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
    APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases.
    Shields KJ; Mollnes TE; Eidet JR; Mikkelsen K; Almdahl SM; Bottazzi B; Lyberg T; Manzi S; Ahearn JM; Hollan I
    PLoS One; 2017; 12(3):e0174577. PubMed ID: 28362874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).
    Jansen JH; Høgåsen K; Mollnes TE
    Am J Pathol; 1993 Nov; 143(5):1356-65. PubMed ID: 8238252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of in vivo complement activation on the Echinococcus granulosus hydatid cyst wall.
    Ferreira AM; Diaz A; Fernandez C; Sim RB
    Parasite Immunol; 2001 Dec; 23(12):655-8. PubMed ID: 11737668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of endometrial tissue specific complement activation in women with endometriosis.
    D'Cruz OJ; Wild RA
    Fertil Steril; 1992 Apr; 57(4):787-95. PubMed ID: 1372870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the alternative pathway of complement by skin immune deposits.
    Schifferli JA; Steiger G; Polla L; Didierjean L; Saurat JH
    J Invest Dermatol; 1985 Nov; 85(5):407-11. PubMed ID: 3902986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic complement activation levels in Stargardt disease.
    Dhooge PPA; Runhart EH; Li CHZ; de Kat Angelino CM; Hoyng CB; van der Molen RG; den Hollander AI
    PLoS One; 2021; 16(6):e0253716. PubMed ID: 34170959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement-activating immune deposits in systemic lupus erythematosus skin.
    Gammon WR; Merritt CC; Henke DC; Robinson T; Henley N; DeAngelo L
    J Invest Dermatol; 1983 Jul; 81(1):14-20. PubMed ID: 6345682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast.
    Leivo I; Engvall E
    J Cell Biol; 1986 Sep; 103(3):1091-100. PubMed ID: 3488995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation in patients with amebic liver abscess.
    Muñoz LE; Salazar OG
    J Hepatol; 1987 Aug; 5(1):30-6. PubMed ID: 2888804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.
    Messias-Reason IJ; Hayashi SY; Nisihara RM; Kirschfink M
    Clin Exp Immunol; 2002 Feb; 127(2):310-5. PubMed ID: 11876755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-mediated endothelial cell damage in immune complex vasculitis of the skin: ultrastructural localization of the membrane attack complex.
    Boom BW; Mommaas M; Daha MR; Vermeer BJ
    J Invest Dermatol; 1989 Aug; 93(2 Suppl):68S-72S. PubMed ID: 2666524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.
    Freysdottir J; Ormarsdottir S; Sigfusson A
    Clin Exp Immunol; 1993 Nov; 94(2):286-90. PubMed ID: 8222319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.